Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data

BACKGROUND: Recent studies have shown fondaparinux's superiority over enoxaparin in patients with non-ST elevation acute coronary syndrome (ACS), especially in relation to bleeding reduction. The description of this finding in a Brazilian registry has not yet been documented. OBJECTIVE: To comp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arq Bras Cardiol
Autores principales: Soeiro, Alexandre de Matos, Silva, Pedro Gabriel Melo de Barros e, Roque, Eduardo Alberto de Castro, Bossa, Aline Siqueira, César, Maria Cristina, Simões, Sheila Aparecida, Okada, Mariana Yumi, Leal, Tatiana de Carvalho Andreucci Torres, Pedroti, Fátima Cristina Monteiro, de Oliveira Jr., Múcio Tavares
Formato: Artigo
Lenguaje:Inglês
Publicado: Sociedade Brasileira de Cardiologia - SBC 2016
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053192/
https://ncbi.nlm.nih.gov/pubmed/27579543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20160127
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares